Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

On October 24, 2022, the Board of Directors (the "Board") of Elevance Health, Inc. (the "Company") elected Deanna Strable-Soethout to serve as an independent director effective November 1, 2022, with a term expiring at the Company's 2023 annual meeting of shareholders. The Board also appointed Ms. Strable-Soethout to the Audit and Governance Committees of the Board. There is no arrangement or understanding between Ms. Strable-Soethout and any other person pursuant to which she was elected to the Board, and Ms. Strable-Soethout has no direct or indirect material interest in any transaction required to be disclosed pursuant to Item 404(a) of Regulation S-K of the Securities Exchange Act of 1934, as amended. The Board has determined that Ms. Strable-Soethout qualifies as an "audit committee financial expert" as defined in the Securities and Exchange Commission regulations.

Ms. Strable-Soethout will receive compensation for her services as a director in accordance with the Company's standard compensation program for non-employee directors, which is filed as Exhibit 10.7 to the Company's Quarterly Report on Form 10-Q for the quarter ended June 30, 2022.

A copy of the Company's press release announcing Ms. Strable-Soethout's election is furnished herewith as Exhibit 99.1.

Item 9.01 Financial Statements and Exhibits.



(d) Exhibits.

Exhibit
  No.       Exhibit

99.1          Press Release, dated October 25, 2022, announcing the election of
            Deanna Strable-Soethout to the Elevance Health, Inc. Board of
            Directors.

104         Cover Page Interactive Data File (embedded within the Inline XBRL
            document)

--------------------------------------------------------------------------------

© Edgar Online, source Glimpses